Medical & Clinical Trials | Clinical Research | BI Clinical Studies
Completed studies for:
All conditions
Study Results
BI 1199-0211
- Results published
- Last Published: 7/22/2026
- Study Ended: 7/22/2025
- VARGADO - Vargatef in 2nd-line Therapy of Non-Small Cell Lung Cancer (NSCLC)
- Condition: Non-Small Cell Lung Cancer
- Publication languages: English
BI 1519-0002
- Results published
- Last Published: 6/29/2026
- Study Ended: 6/4/2025
- A Study to Test How Different Doses of BI 3731579 Are Tolerated by Healthy People
- Condition: Healthy Participants
- Publication languages: English
BI 1519-0004
- Results published
- Last Published: 6/29/2026
- Study Ended: 4/22/2025
- A Study in Healthy Men to Test Whether Food Influences the Amount of BI 3731579 in the Blood
- Condition: Healthy Participants
- Publication languages: English
BI 1519-0001
- Results published
- Last Published: 6/29/2026
- Study Ended: 5/26/2025
- A Study in Healthy Men to Test How Well Different Doses of BI 3731579 Are Tolerated
- Condition: Healthy Participants
- Publication languages: English
BI 1505-0001
- Results published
- Last Published: 6/19/2026
- Study Ended: 6/18/2025
- A Study to Find a Suitable Dose of BI 765883 and to Test Whether it Helps People With Advanced Pancreatic Cancer When Taken Alone or Together With Chemotherapy
- Condition: Pancreatic Cancer
- Publication languages: English
BI 1479-0020
- Results published
- Last Published: 6/19/2026
- Study Ended: 6/19/2025
- A Study to Test How Zongertinib is Taken up in the Blood of People With and Without Liver Problems
- Condition: Healthy Participants, Hepatic Impairment
- Publication languages: English
BI 1447-0012
- Results published
- Last Published: 5/21/2026
- Study Ended: 5/11/2025
- A Study to Test Different Doses of BI 1569912 in People With Depression
- Condition: Depression
- Publication languages: English
BI 1447-0001
- Results published
- Last Published: 5/20/2026
- Study Ended: 9/9/2021
- A Study in Healthy Men to Test How Well Different Doses of BI 1569912 Are Tolerated and How Food Influences the Amount of BI 1569912 in the Blood
- Condition: Healthy participants
- Publication languages: English
BI 1447-0003
- Results published
- Last Published: 5/20/2026
- Study Ended: 11/15/2023
- A Study to Test How Well Different Doses of BI 1569912 Are Tolerated and How Well They Work in People With Depression Who Take Anti-depressive Medication
- Condition: Major depressive disorder
- Publication languages: English
BI 1447-0004
- Results published
- Last Published: 5/20/2026
- Study Ended: 10/29/2023
- A Study in Healthy Japanese Men to Test How Different Doses of BI 1569912 Are Taken up by the Body and How Well They Are Tolerated
- Condition: Healthy Volunteers
- Publication languages: English
BI 1447-0002
- Results published
- Last Published: 5/20/2026
- Study Ended: 7/3/2024
- A Study in Healthy Men to Test How Well Different Doses of BI 1569912 Are Tolerated
- Condition: Healthy participants
- Publication languages: English
BI 1447-0007
- Results published
- Last Published: 5/20/2026
- Study Ended: 8/19/2024
- A Study in Healthy Men and Women to Test Whether BI 1569912 Influences the Amount of Repaglinide, Midazolam and Bupropion in the Blood
- Condition: Healthy Participants
- Publication languages: English
BI 1447-0010
- Results published
- Last Published: 5/20/2026
- Study Ended: 10/2/2024
- A Study in Healthy Men to Test How BI 1569912 is Processed in the Body
- Condition: Healthy Participants
- Publication languages: English
BI 1199-0393
- Results published
- Last Published: 5/12/2026
- Study Ended: 5/13/2025
- NICEFIT-ON: A Study Under Routine Clinical Practice in Taiwan to Observe the Long-term Outcome of People With Certain Types of Lung Disease (PF-ILD, SSc-ILD, IPF) Who Start Treatment With Nintedanib
- Condition:
- Publication languages: English
BI 1509-0001
- Results published
- Last Published: 5/12/2026
- Study Ended: 11/12/2023
- A Study in Healthy Men to Test How Different Doses of BI 3000202 Are Tolerated and How Food Influences the Amount of BI 3000202 in the Blood
- Condition: Healthy participants
- Publication languages: English
BI 1434-0016
- Results published
- Last Published: 5/7/2026
- Study Ended: 11/8/2023
- A Study in Healthy Men to Test How BI 764198 is Processed in the Body
- Condition:
- Publication languages: English
BI 1484-0003
- Results published
- Last Published: 5/7/2026
- Study Ended: 11/9/2023
- A Study in Healthy Men to Test Whether Itraconazole Influences the Amount of BI 1584862 in the Blood
- Condition: Healthy participants
- Publication languages: English
BI 1245-0276
- Results published
- Last Published: 4/29/2026
- Study Ended: 4/29/2025
- Jardiance® Post Marketing Surveillance (PMS) in Korean Patients With Chronic Heart Failure
- Condition:
- Publication languages: English
BI 1245-0323
- Results published
- Last Published: 4/29/2026
- Study Ended: 4/29/2025
- JARDIANCE® Post Marketing Surveillance in Korean Patients With Chronic Kidney Disease (CKD)
- Condition: Chronic kidney disease
- Publication languages: English
BI 1467-0001
- Results published
- Last Published: 4/21/2026
- Study Ended: 4/9/2025
- A Study to Find a Suitable Dose of BI 1821736 and Test Whether it Helps People With Advanced Cancer
- Condition: Solid Tumors
- Publication languages: English
BI 1485-0003
- Results published
- Last Published: 4/21/2026
- Study Ended: 10/23/2023
- A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 1815368 in the Blood
- Condition: Healthy participants
- Publication languages: English
BI 1160-0309
- Results published
- Last Published: 4/21/2026
- Study Ended: 4/27/2025
- A Study in the United States That Looks at the Safety and Effectiveness of Pradaxa Pellets in Children Aged 3 Months to Less Than 12 Years Who Need Treatment of a Blood Clot or Who Have Had a Blood Clot and Are at Risk of Developing Another Blood Clot
- Condition: Venous thromboembolism
- Publication languages: English
BI 1199-0545
- Results published
- Last Published: 4/21/2026
- Study Ended: 4/28/2025
- A Study Based on Medical Records in Spain That Looks at Diarrhoea Control in People With Pulmonary Fibrosis Who Are Taking Nintedanib
- Condition: Pulmonary fibrosis
- Publication languages: English
BI 1368-0130
- Results published
- Last Published: 4/15/2026
- Study Ended: 4/10/2025
- A Study to Test Long-term Treatment With Spesolimab in People With a Skin Condition Disease Called Hidradenitis Suppurativa (HS) Who Took Part in a Previous Study With Spesolimab
- Condition: Hidradenitis suppurativa
- Publication languages: English
BI 1199-0378
- Results published
- Last Published: 4/10/2026
- Study Ended: 8/12/2025
- A Study to Evaluate Long-term Safety of Nintedanib in Children and Adolescents With Interstitial Lung Disease (InPedILD®-ON)
- Condition: Interstitial lung disease
- Publication languages: English
BI 1368-0098
- Results published
- Last Published: 4/7/2026
- Study Ended: 3/30/2025
- Lunsayil 1: A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Hidradenitis Suppurativa
- Condition: Hidradenitis suppurativa
- Publication languages: English
BI 1368-0121
- Results published
- Last Published: 3/30/2026
- Study Ended: 3/30/2025
- Natural History of Netherton Syndrome
- Condition: Netherton syndrome
- Publication languages: English
BI 1346-0019
- Results published
- Last Published: 3/19/2026
- Study Ended: 5/27/2019
- A Study in Healthy People to Test if Taking Different Formulations of BI 425809 Tablets Influences the Amount of BI 425809 in the Blood
- Condition: Healthy participants
- Publication languages: English
BI 1346-0035
- Results published
- Last Published: 3/19/2026
- Study Ended: 5/30/2022
- A Study in Healthy Men to Test Whether BI 425809 Influences the Amount of Midazolam in the Blood
- Condition:
- Publication languages: English
BI 1346-0047
- Results published
- Last Published: 3/19/2026
- Study Ended: 10/23/2023
- A Study to Test How Iclepertin is Taken up in the Blood of People With and Without Kidney Problems
- Condition:
- Publication languages: English
BI 1346-0018
- Results published
- Last Published: 3/17/2026
- Study Ended: 6/19/2017
- A Study in Healthy Men to Test Whether Rifampicin Influences the Amount of BI 425809 in the Blood
- Condition: Healthy participants
- Publication languages: English
BI 1346-0016
- Results published
- Last Published: 3/17/2026
- Study Ended: 11/11/2018
- A Study in Healthy Men to Find Out How BI 425809 is Taken up and Handled by the Body
- Condition: Healthy participants
- Publication languages: English
BI 1346-0017
- Results published
- Last Published: 3/17/2026
- Study Ended: 1/9/2022
- A Study in Healthy Men to Test How Fluconazole Influences the Amount of BI 425809 in the Blood
- Condition: Healthy participants
- Publication languages: English
BI 1346-0053
- Results published
- Last Published: 3/17/2026
- Study Ended: 12/27/2022
- A Study in Healthy People to Test How BI 425809 is Taken up in the Body When Taken With or Without Food
- Condition:
- Publication languages: English
BI 1346-0036
- Results published
- Last Published: 3/17/2026
- Study Ended: 10/3/2023
- A Study in Healthy Women to Test Whether BI 425809 Influences the Amount of a Contraceptive in the Blood
- Condition:
- Publication languages: English
BI 1346-0056
- Results published
- Last Published: 3/17/2026
- Study Ended: 5/25/2023
- A Study in Healthy Men to Test Whether Bosentan Influences the Amount of BI 425809 in the Blood
- Condition:
- Publication languages: English
BI 1346-0048
- Results published
- Last Published: 3/17/2026
- Study Ended: 12/10/2023
- A Study to Test How Iclepertin is Taken up in the Blood of People With and Without Liver Problems
- Condition:
- Publication languages: English
BI 1346-0051
- Results published
- Last Published: 3/17/2026
- Study Ended: 6/4/2024
- A Study in Healthy People to Test Whether Iclepertin Has an Effect on Cardiac Safety
- Condition: Healthy participants
- Publication languages: English
BI 1346-0015
- Results published
- Last Published: 3/10/2026
- Study Ended: 3/5/2019
- A Study in Healthy Men to Measure the Amount of BI 425809 in the Blood When Taken as a Tablet
- Condition: Healthy participants
- Publication languages: English
BI 1346-0001
- Results published
- Last Published: 3/10/2026
- Study Ended: 9/9/2014
- Safety, Tolerability, and Pharmacokinetics of Single Doses BI 425809
- Condition: Healthy participants
- Publication languages: English
BI 1346-0002
- Results published
- Last Published: 3/10/2026
- Study Ended: 11/15/2015
- Safety, Tolerability, and Pharmacokinetics of Multiple Rising Doses of BI 425809 Tablets for 12 Days to Young and Elderly Healthy Male and Female Volunteers and Comparison of Pharmacokinetics of a Single Oral Dose of BI 425809 (Morning Versus Evening)
- Condition: Healthy participants
- Publication languages: English
BI 1346-0010
- Results published
- Last Published: 3/10/2026
- Study Ended: 2/28/2015
- Relative Bioavailability of a Single Oral Dose of BI 425809 When Administered Alone or in Combination With Multiple Oral Doses of Itraconazole in Healthy Male Subjects
- Condition: Healthy participants
- Publication languages: English
BI 1346-0003
- Results published
- Last Published: 3/10/2026
- Study Ended: 6/18/2015
- Pharmacokinetics and Pharmacodynamic Effect of Different Multiple Oral Doses of BI 425809
- Condition: Healthy participants
- Publication languages: English
BI 1346-0004
- Results published
- Last Published: 3/10/2026
- Study Ended: 8/5/2015
- Single Rising Dose Trial of BI 425809 for Healthy Japanese and Chinese Male Subjects
- Condition: Healthy participants
- Publication languages: English
BI 1346-0022
- Results published
- Last Published: 3/10/2026
- Study Ended: 10/29/2015
- Interaction of BI 425809 With Midazolam, Warfarin, Omeprazole and Digoxin
- Condition: Healthy participants
- Publication languages: English
BI 1346-0014
- Results published
- Last Published: 2/24/2026
- Study Ended: 3/17/2025
- A Study to Test Long-term Safety of Iclepertin in People With Schizophrenia Who Took Part in a Previous CONNEX Study
- Condition: Schizophrenia
- Publication languages: English
BI 1447-0005
- Results published
- Last Published: 2/24/2026
- Study Ended: 3/27/2025
- A Study to Test Different Doses of BI 1569912 in People With Depression Who Take Anti-depressive Medicine
- Condition: Depressive disorder
- Publication languages: English
BI 1305-0014
- Results published
- Last Published: 2/23/2026
- Study Ended: 12/16/2024
- A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)
- Condition: Idiopathic pulmonary fibrosis
- Publication languages: English
BI 1305-0023
- Results published
- Last Published: 2/23/2026
- Study Ended: 4/13/2025
- A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs)
- Condition: Progressive Fibrosing Interstitial Lung Disease
- Publication languages: English
BI 1368-0104
- Results published
- Last Published: 1/29/2026
- Study Ended: 7/30/2025
- A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Netherton Syndrome
- Condition: Netherton Syndrome
- Publication languages: English
Load more studies.